Deutsche Bank AG Reduces Stock Position in U.S. Physical Therapy, Inc. $USPH

Deutsche Bank AG cut its holdings in U.S. Physical Therapy, Inc. (NYSE:USPH) by 9.5% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 11,924 shares of the company’s stock after selling 1,252 shares during the period. Deutsche Bank AG owned about 0.08% of U.S. Physical Therapy worth $863,000 at the end of the most recent reporting period.

Several other hedge funds have also recently made changes to their positions in USPH. Point72 Asset Management L.P. purchased a new position in U.S. Physical Therapy in the fourth quarter worth about $18,886,000. Nuveen Asset Management LLC raised its position in U.S. Physical Therapy by 95.9% during the fourth quarter. Nuveen Asset Management LLC now owns 120,893 shares of the company’s stock valued at $10,724,000 after purchasing an additional 59,190 shares during the period. Silvercrest Asset Management Group LLC lifted its stake in shares of U.S. Physical Therapy by 24.8% in the 4th quarter. Silvercrest Asset Management Group LLC now owns 189,115 shares of the company’s stock valued at $16,776,000 after purchasing an additional 37,523 shares during the last quarter. Northern Trust Corp lifted its stake in shares of U.S. Physical Therapy by 13.9% in the 4th quarter. Northern Trust Corp now owns 261,825 shares of the company’s stock valued at $23,226,000 after purchasing an additional 32,024 shares during the last quarter. Finally, GW&K Investment Management LLC boosted its holdings in shares of U.S. Physical Therapy by 8.9% in the 1st quarter. GW&K Investment Management LLC now owns 344,390 shares of the company’s stock worth $24,920,000 after purchasing an additional 28,203 shares during the period.

Wall Street Analysts Forecast Growth

Several analysts recently weighed in on the company. Zacks Research upgraded U.S. Physical Therapy to a “hold” rating in a report on Friday, August 8th. Wall Street Zen raised shares of U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research note on Thursday, May 8th. Finally, Barrington Research boosted their price objective on shares of U.S. Physical Therapy from $98.00 to $103.00 and gave the company an “outperform” rating in a research report on Friday, August 8th. One research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $110.25.

Insiders Place Their Bets

In other news, COO Graham D. Reeve sold 763 shares of the company’s stock in a transaction dated Thursday, August 21st. The shares were sold at an average price of $84.97, for a total value of $64,832.11. Following the transaction, the chief operating officer directly owned 21,483 shares in the company, valued at approximately $1,825,410.51. This represents a 3.43% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Nancy Ham sold 400 shares of the firm’s stock in a transaction dated Thursday, June 12th. The stock was sold at an average price of $78.01, for a total transaction of $31,204.00. Following the completion of the transaction, the director directly owned 2,594 shares in the company, valued at $202,357.94. This represents a 13.36% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 2,955 shares of company stock valued at $251,170 over the last three months. Insiders own 2.00% of the company’s stock.

U.S. Physical Therapy Trading Up 3.6%

USPH opened at $87.5170 on Monday. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.18 and a current ratio of 1.18. The stock’s 50 day moving average price is $78.26 and its 200-day moving average price is $76.75. U.S. Physical Therapy, Inc. has a one year low of $62.77 and a one year high of $101.19. The stock has a market cap of $1.33 billion, a price-to-earnings ratio of 38.22, a P/E/G ratio of 4.47 and a beta of 1.45.

U.S. Physical Therapy (NYSE:USPH) last posted its quarterly earnings data on Wednesday, August 6th. The company reported $0.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.71 by $0.10. The company had revenue of $197.34 million during the quarter, compared to analysts’ expectations of $190.24 million. U.S. Physical Therapy had a return on equity of 8.78% and a net margin of 5.05%.U.S. Physical Therapy’s revenue was up 18.0% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.73 EPS. On average, equities analysts forecast that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current year.

U.S. Physical Therapy Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, September 12th. Stockholders of record on Friday, August 22nd will be paid a dividend of $0.45 per share. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.1%. The ex-dividend date of this dividend is Friday, August 22nd. U.S. Physical Therapy’s payout ratio is currently 78.60%.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.